The Scan

NPR reports on an Alzheimer's disease drug trial that is continuing despite the pandemic.

The New York Times reports on how the US Food and Drug Administration has attempted to gird against pressure from the White House.

Researchers have identified a gene involved in how people determine when to urinate.

The Guardian reports that the UK COVID genomics consortium is monitoring mutations that are arising within circulating SARS-CoV-2 strains for any that may affect future vaccines.

Science reports that Max Planck and Nature have struck a deal for affiliated authors to publish papers that are accessible to the public as well as access Nature-branded journals.

Bloomberg reports the US Centers for Medicare & Medicaid Services sent Orig3n a letter saying it has not corrected lab issues uncovered in an earlier inspection.

A new survey finds people in the US are getting their COVID-19 test results back faster, but not fast enough to help some viral control measures, NPR reports.

New Scientist reports that a new genetic analysis suggests some saber-toothed cats may have lived in packs and been fast runners.

PLOS is piloting a new model under which research institutions pay a flat fee for its researchers to publish in its journals, Science reports.

Reuters reports University of Oxford researchers have developed a test for SARS-CoV-2 that can return results in five minutes.

The Washington Post reports that a herd immunity proposal has found a receptive audience at the White House to the dismay of most scientists.

The Wall Street Journal reports clinical labs are grappling with staffing shortages, an issue exacerbated by the pandemic.